| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |